Visfatin: The Link Between Inflammation and Childhood Obesity
Author(s) -
George Dedoussis,
Alexandra Kapiri,
Anastasia Samara,
Dimitris Dimitriadis,
Daniel Lambert,
Michèle Pfister,
Gérard Siest,
Sophie VisvikisSiest
Publication year - 2009
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc08-2304
Subject(s) - adipokine , medicine , adipose tissue , inflammation , obesity , tumor necrosis factor alpha , endocrinology , diabetes mellitus , systemic inflammation , childhood obesity , insulin resistance , overweight
Low-grade inflammation that coexists with obesity has mainly been studied in adults, whereas data in children are limited. Visfatin is a newly discovered adipokine. It is expressed in visceral adipose tissue and has been shown to exert insulin-mimetic effects (1). Although some studies have addressed its relation to obesity, visfatin's biological roles are largely unknown. Besides expression in adipose tissue, visfatin is also expressed in peripheral blood neutrophils upon stimulation by inflammatory factors, such as tumor necrosis factor-α (TNF-α) (2).In light of the rising prevalence of pediatric obesity, it is important to assess the role of visfatin as a predictor of BMI and to unravel its association with inflammation markers. To address this, we measured its …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom